ABSTRACT
India is experiencing a new surge in Covid-19 cases in most parts of the country. A new sub-variant of Omicron, XBB.1.16 which is far more aggressive and immune evasive than other sub-lineages of Omicron, is responsible for this outbreak. In this preliminary account, we describe key clinical characteristics of SARS-CoV-2 infected children, visiting an outdoor department of a pediatric hospital in a north Indian city. Our preliminary findings show a higher involvement of young infants than older children and mild respiratory illness predominates other presentations. One interesting finding was the presence of itchy, non-purulent conjunctivitis with mucoid discharge and stickiness of eyelids in 42.8% of positive infants. None of the children required hospitalization. All recovered with symptomatic treatment.
Key findings
The current ongoing XBB.1.16 driven surge of Covid-19 is causing mild febrile illness in children in India
Young infants are disproportionately more affected than older children.
Unlike the previous BA.2 Omicron wave, respiratory symptoms are predominating the clinical presentation in young infants in the ongoing surge.
Conjunctival involvement is seen in 42.8% of affected infants.
Competing Interest Statement
The authors have declared no competing interest.
Funding Statement
This study did not receive any funding
Author Declarations
I confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.
Yes
The details of the IRB/oversight body that provided approval or exemption for the research described are given below:
Ethical approval to perform this study has been approved by the Institutional Ethics Committee, Mangla Hospital & Research Centre, Bijnor, Uttar Pradesh, India, which is affiliated with the Institutional Review Board of Christian Medical College, Vellore, India (Ethics approval letter: MHRC/IEC/2023/03 dated April 3, 2023).
I confirm that all necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived, and that any patient/participant/sample identifiers included were not known to anyone (e.g., hospital staff, patients or participants themselves) outside the research group so cannot be used to identify individuals.
Yes
I understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).
Yes
I have followed all appropriate research reporting guidelines, such as any relevant EQUATOR Network research reporting checklist(s) and other pertinent material, if applicable.
Yes
Footnotes
Email ID: vipinipsita{at}gmail.com
E-mail: KumarChildClinic{at}gmail.com
Conflicts of interests: None
Funding: None
Data Availability
All data produced in the present work are contained in the manuscript
